Figure 1.
MiR-154-5p is downregulated in NPC tissues and cells and closely correlated with clinical features. (A) Relative expression of miR-154-5p in NPC tissues (n=40) and normal nasopharyngeal epithelial tissues (n=8). (B) Expression of miR-154-5p in NPC tissues of patients with different clinical N stages. (C) Expression of miR-154-5p in metastatic nasopharyngeal carcinoma tissues (M1) and in non-metastatic tissues (M0). (D) Expression of miR-154-5p in NPC cell lines. *P<0.05, **P<0.01.